Literature DB >> 29563729

Operable Oral Tongue Squamous Cell Cancer: 15 Years Experience at a Tertiary Care Center in North India.

Nootan Kumar Shukla1, S V Suryanarayana Deo1, Pankaj Kumar Garg1,2, N M L Manjunath1, Suman Bhaskar3, V Sreenivas4.   

Abstract

The aim of the present study was to provide insight into various demographic, clinical, and management profile of Indian patients with oral tongue squamous cell cancer (OTSCC). All the OTSCC patients who had undergone surgical treatment during 1995 to 2010 at a tertiary care center in North India were considered for the present study. The details of the patients were retrieved from a prospectively maintained computerized database. A total of 124 patients were included in the present study. Mean age of the patients was 50.4 ± 12.0 years. Lateral border of the tongue was the most common sub-site involved in 110 (88.7%) patients. Neck nodes were clinically palpable in 56.4% patients. Hemiglossectomy and anterior partial glossectomy were common surgical procedure undertaken in 57.2 and 25.8% patients. Negative resection margin was achieved in 97.5% patients. Pathological neck metastasis was seen in 40.3% patients. Occult neck metastasis was present in 25.9% patients among clinical N0 neck. At a mean follow-up of 29.8 months (SD 3.1), 20.1% developed disease relapse and 4.0% patients developed second primaries. Kaplan-Meier analysis estimated a 5-year disease-free survival of 81.5% and a 5 years overall survival of 78.6%. Cox proportional regression analysis predicted tumor size and number of positive nodes to be independent predictive variables for disease recurrence. Quality controlled surgery, coupled with adjuvant treatment when required, provides a safe and effective treatment of OTSCC with a good disease-free survival and loco-regional control.

Entities:  

Keywords:  Chemotherapy; Glossectomy; Oral neoplasms; Radiotherapy; Survival analysis; Tongue neoplasms

Year:  2017        PMID: 29563729      PMCID: PMC5856685          DOI: 10.1007/s13193-017-0658-x

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  27 in total

1.  Treatment outcome with low-dose-rate interstitial brachytherapy in early-stage oral tongue cancers.

Authors:  Rajendra I Bhalavat; Umesh M Mahantshetty; Sanjay Tole; Swamidas V Jamema
Journal:  J Cancer Res Ther       Date:  2009 Jul-Sep       Impact factor: 1.805

2.  Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck.

Authors:  Jay S Cooper; Qiang Zhang; Thomas F Pajak; Arlene A Forastiere; John Jacobs; Scott B Saxman; Julie A Kish; Harold E Kim; Anthony J Cmelak; Marvin Rotman; Robert Lustig; John F Ensley; Wade Thorstad; Christopher J Schultz; Sue S Yom; K Kian Ang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-06-30       Impact factor: 7.038

3.  Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue?

Authors:  R M Byers; A K El-Naggar; Y Y Lee; B Rao; B Fornage; N H Terry; D Sample; P Hankins; T L Smith; P J Wolf
Journal:  Head Neck       Date:  1998-03       Impact factor: 3.147

4.  Predictors of prognosis for squamous cell carcinoma of oral tongue.

Authors:  Shivakumar Thiagarajan; Sudhir Nair; Deepa Nair; Pankaj Chaturvedi; Shubhadra V Kane; Jai Prakash Agarwal; Anil K D'Cruz
Journal:  J Surg Oncol       Date:  2014-03-12       Impact factor: 3.454

5.  Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).

Authors:  Jacques Bernier; Jay S Cooper; T F Pajak; M van Glabbeke; J Bourhis; Arlene Forastiere; Esat Mahmut Ozsahin; John R Jacobs; J Jassem; Kie-Kian Ang; J L Lefèbvre
Journal:  Head Neck       Date:  2005-10       Impact factor: 3.147

6.  Clinicopathological prognostic factors of oral tongue squamous cell carcinoma: a retrospective study of 202 cases.

Authors:  P C Rodrigues; M C C Miguel; E Bagordakis; F P Fonseca; S N de Aquino; A R Santos-Silva; M A Lopes; E Graner; T Salo; L P Kowalski; R D Coletta
Journal:  Int J Oral Maxillofac Surg       Date:  2014-02-28       Impact factor: 2.789

7.  Intraoral sonography-assisted resection of T1-2 tongue cancer for adequate deep resection.

Authors:  Chung-Hwan Baek; Young-Ik Son; Han-Sin Jeong; Man Ki Chung; Ki-Nam Park; Young-Hyeh Ko; Hyung-Jin Kim
Journal:  Otolaryngol Head Neck Surg       Date:  2008-12       Impact factor: 3.497

8.  Management of the patients with early stage oral tongue cancers.

Authors:  Kiyoto Shiga; Takenori Ogawa; Shun Sagai; Kengo Kato; Toshimitsu Kobayashi
Journal:  Tohoku J Exp Med       Date:  2007-08       Impact factor: 1.848

9.  Unilateral, clinically T2N0, squamous cell carcinoma of the tongue: surgical outcome analysis.

Authors:  Y C Lim; E C Choi
Journal:  Int J Oral Maxillofac Surg       Date:  2007-03-06       Impact factor: 2.789

10.  Computerized clinical database development in oncology.

Authors:  Svs Deo
Journal:  Indian J Palliat Care       Date:  2011-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.